Cargando…

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Pierro, Francesco, Iqtadar, Somia, Khan, Amjad, Ullah Mumtaz, Sami, Masud Chaudhry, Mohsin, Bertuccioli, Alexander, Derosa, Giuseppe, Maffioli, Pamela, Togni, Stefano, Riva, Antonella, Allegrini, Pietro, Khan, Saeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238537/ https://www.ncbi.nlm.nih.gov/pubmed/34194240 http://dx.doi.org/10.2147/IJGM.S318949

Ejemplares similares

Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
por: Di Pierro, Francesco, et al.
Publicado: (2023)

Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
por: Di Pierro, Francesco, et al.
Publicado: (2021)

Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study
por: Di Pierro, Francesco, et al.
Publicado: (2022)

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
por: Khan, Amjad, et al.
Publicado: (2022)

Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes – a case series from Lahore, Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2022)

Vitamin D Deficiency (VDD) and Susceptibility towards Severe Dengue Fever—A Prospective Cross-Sectional Study of Hospitalized Dengue Fever Patients from Lahore, Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2023)

Papillon-Lèfevre syndrome with palmoplantar keratoderma and periodontitis, a rare cause of pyrexia of unknown origin: a case report
por: Iqtadar, Somia, et al.
Publicado: (2015)

Soothing and anti-itch effect of quercetin phytosome in human subjects: a single-blind study
por: Maramaldi, Giada, et al.
Publicado: (2016)

Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
por: Riva, Antonella, et al.
Publicado: (2018)

Clinical Audit of Dengue Related Deaths in 2011-Mayo Hospital Lahore Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2017)

α-Glucosidase inhibitors and their use in clinical practice
por: Derosa, Giuseppe, et al.
Publicado: (2012)

Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients
por: Khan, Dur Muhammad, et al.
Publicado: (2017)

The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
por: Ujjan, Ikram Din, et al.
Publicado: (2023)

The Human Microbial Metabolism of Quercetin in Different Formulations: An In Vitro Evaluation
por: Di Pede, Giuseppe, et al.
Publicado: (2020)

Amlodipine/Valsartan (Avsar®): Efficacy in Hypertensive Patients - A Real World Observational Study (ALERT)
por: Khan, Khalid M, et al.
Publicado: (2020)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2011)

Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
por: Guasti, Luigina, et al.
Publicado: (2017)

An overview of CAR T-cell clinical trial activity to 2021
por: Adami, Antonella, et al.
Publicado: (2021)

Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
por: Derosa, Giuseppe, et al.
Publicado: (2021)

Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
por: Derosa, Giuseppe, et al.
Publicado: (2019)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

Screening of ZIKA virus infection among dengue-like illness patients with negative RT-PCR for dengue virus in Punjab – Pakistan
por: Iqtadar, Somia, et al.
Publicado: (2021)

Profile of hepatic involvement in dengue infections in adult Pakistani population
por: Iqtadar, Somia, et al.
Publicado: (2017)

Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention
por: Derosa, Giuseppe, et al.
Publicado: (2020)

A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients
por: Derosa, Giuseppe, et al.
Publicado: (2016)

When healers get wounded! Moral injury in healthcare providers during the COVID-19 pandemic in Pakistan
por: Fatima, Madah, et al.
Publicado: (2023)

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
por: Khan, Haroon, et al.
Publicado: (2019)

Neuroprotective Effect of Quercetin Against the Detrimental Effects of LPS in the Adult Mouse Brain
por: Khan, Amjad, et al.
Publicado: (2018)

A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus
por: Derosa, Giuseppe, et al.
Publicado: (2016)

A curious case of hypoglycaemia
por: Derosa, Giuseppe, et al.
Publicado: (2013)

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2018)

Mitigating the Effects of Nonadherence in Clinical Trials
por: Shiovitz, Thomas M., et al.
Publicado: (2016)

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
por: Derosa, Giuseppe, et al.
Publicado: (2018)

Promising Effects of 3-Month Period of Quercetin Phytosome(®) Supplementation in the Prevention of Symptomatic COVID-19 Disease in Healthcare Workers: A Pilot Study
por: Rondanelli, Mariangela, et al.
Publicado: (2022)

Building Resilience Against ViolencE (BRAVE): protocol of a parenting intervention for mothers and fathers with post-traumatic stress disorder in Pakistan
por: Chaudhry, Nasim, et al.
Publicado: (2022)

Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022)

Preventative therapy for breast cancer: a clinical experience
por: Law, Rebekah, et al.
Publicado: (2023)

Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2016)

Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota
por: Bertuccioli, Alexander, et al.
Publicado: (2022)

Diagnosing Primary Sclerosing Cholangitis in Children
por: Seerat, Iqtadar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ue1vmk3ek0cvkghifkotmmmrc